Barclays’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4532 |
|
|
2025
Q1 | – | Sell |
-145,999
| Closed | -$76K | – | 4529 |
|
|
2024
Q4 | $76K | Hold |
145,999
| – | – | ﹤0.01% | 3852 |
|
|
2024
Q3 | $473K | Hold |
145,999
| – | – | ﹤0.01% | 3027 |
|
|
2024
Q2 | $438K | Hold |
145,999
| – | – | ﹤0.01% | 2605 |
|
|
2024
Q1 | $679K | Hold |
145,999
| – | – | ﹤0.01% | 2657 |
|
|
2023
Q4 | $604K | Hold |
145,999
| – | – | ﹤0.01% | 2903 |
|
|
2023
Q3 | $438K | Hold |
145,999
| – | – | ﹤0.01% | 2621 |
|
|
2023
Q2 | $359K | Buy |
145,999
+131,161
| +884% | +$323K | ﹤0.01% | 2789 |
|
|
2023
Q1 | $33K | Buy |
14,838
+5,411
| +57% | +$12K | ﹤0.01% | 3882 |
|
|
2022
Q4 | $33K | Buy |
9,427
+2,326
| +33% | +$8.14K | ﹤0.01% | 3910 |
|
|
2022
Q3 | $263K | Sell |
7,101
-9,598
| -57% | -$355K | ﹤0.01% | 2943 |
|
|
2022
Q2 | $317K | Buy |
16,699
+14,999
| +882% | +$285K | ﹤0.01% | 2868 |
|
|
2022
Q1 | $46K | Buy |
+1,700
| New | +$46K | ﹤0.01% | 4036 |
|